SERVICE SPECIFICATION
Apixmed Prism
(Integral part of the Public Offer)
Edition of November 3, 2026
1. GENERAL PROVISIONS
1.1. This Specification is an integral part of the Apixmed Prism Public Offer and defines the list of available Services, their composition and cost.
1.2. Each Service includes a DNA kit for saliva collection and laboratory DNA analysis. The kit is delivered by Nova Poshta. Purchasing a DNA kit without interpretation is impossible — each order includes at least one Test of the Customer's choice. The Contractor may refuse to provide the service if the Customer did not collect the biomaterial (saliva) of sufficient quality for analysis (determined by the laboratory).
1.3. The results are presented in the Personal Account (online) and/or sent in PDF format to the Customer's email. The terms of provision are determined by the Public Offer.
1.4. All results are for informational purposes only and do not constitute a medical diagnosis.
1.5. The indicators of each Test are presented in two groups: complex indicators calculated by the polygenic risk score method (tens and hundreds of genetic variants together shape the contribution to a predisposition), and individual genetic variants with a described mechanistic link, which are interpreted separately and are not included in the complex indicators.
2. COST OF SERVICES
2.1. Current prices for Services:
- DNA kit + 1 Test of your choice: 9,999 UAH (price without discount — 12,500 UAH)
- Wellness Panel (DNA kit + 5 Tests): 17,200 UAH (price without discount — 22,500 UAH)
- Ultima Panel (DNA kit + 25 Tests + specialist consultation): 29,999 UAH (price without discount — 50,000 UAH)
2.2. Prices are indicated in hryvnias (UAH). Payment is made online by bank card on the Site or by bank transfer to the details of the Contractor. The cost of DNA kit delivery is included in the price of the Service.
2.3. The Contractor reserves the right to change prices in accordance with clause 12.4 of the Public Offer. Changes do not apply to already paid orders.
2.4. The Contractor may provide special offers and discounts; all prices are indicated for informational purposes, and the final price at which the Customer purchased the Service is the one that applies.
3. DNA KIT
3.1. DNA kit is a means of collecting biomaterial (saliva), which is included in every Service. Purchasing a DNA kit separately without interpreting at least one Test is impossible.
3.2. The DNA kit includes:
- Saliva collection kit from the manufacturer
- Protective gloves
- Sample packaging envelope
- Step-by-step instructions for collecting biomaterial
3.3. Upon completion of the laboratory analysis, the Customer receives a raw genetic data file in a format compatible with Apixmed Prism interpretation services.
4. TESTS (SEPARATE SERVICES)
4.1. A Test is a separate Service with a specific thematic list of genetic indicators. The Apixmed Prism programme comprises 26 Tests (directions). A Test is ordered together with a DNA kit and laboratory analysis.
4.2. Vitamins and Micronutrients
Number of indicators: 58 (30 complex indicators and 28 individual genetic variants).
Complex indicators — type: polygenic risk
Fat-soluble vitamins
- Vitamin A (retinol) — polygenic risk
- Vitamin D (25(OH)D) — polygenic risk
- Vitamin D-binding protein — polygenic risk
- Vitamin E — polygenic risk
- Vitamin K1 (phylloquinone) — polygenic risk
Water-soluble vitamins and transport proteins
- Vitamin B1 (thiamine) — polygenic risk
- Vitamin B3 (niacin) — polygenic risk
- Vitamin B5 (pantothenic acid) — polygenic risk
- Vitamin B6 — polygenic risk
- Vitamin B9 (folate) — polygenic risk
- Vitamin B12 (cobalamin) — polygenic risk
- Transcobalamin-1 — polygenic risk
- Vitamin C — polygenic risk
Carotenoids
- Lycopene — polygenic risk
Electrolytes
- Sodium — polygenic risk
- Potassium — polygenic risk
- Chloride — polygenic risk
Macrominerals
- Calcium — polygenic risk
- Phosphorus — polygenic risk
- Magnesium — polygenic risk
Iron status
- Iron — polygenic risk
- Ferritin — polygenic risk
- Transferrin — polygenic risk
- Total iron-binding capacity — polygenic risk
- Transferrin saturation — polygenic risk
Trace elements
- Zinc — polygenic risk
- Selenium — polygenic risk
- Copper — polygenic risk
- Molybdenum — polygenic risk
- Cobalt — polygenic risk
Individual genetic variants — type: functional variant
- CYP24A1 rs6068816 [vitamin D catabolism] — functional variant
- CYP2R1 rs10741657 [25-hydroxyvitamin D] — functional variant
- CYP2R1 rs7129781 [vitamin D 25-hydroxylation] — functional variant
- DHCR7/NADSYN1 rs12785878 [vitamin D precursor synthesis] — functional variant
- GC rs2282679 [25-hydroxyvitamin D; vitamin-D binding protein] — functional variant
- GC rs4588 [vitamin D transport] — functional variant
- GC rs7041 [vitamin D transport] — functional variant
- GC rs705117 [vitamin D transport] — functional variant
- NADSYN1 rs12286616 [vitamin D precursor synthesis] — functional variant
- POR rs41301394 [P450 oxidoreductase, vitamin D enzymes] — functional variant
- SULT2A1 rs2910400 [vitamin D metabolite sulfation] — functional variant
- VDR FokI (rs2228570) [vitamin D] — functional variant
- CYP4F2 V433M (rs2108622) [vitamin K / warfarin] — functional variant
- ALPL (rs1256335) — functional variant
- NBPF3 (rs4654748) — functional variant
- MTHFR A1298C (rs1801131) [folate & homocysteine] — functional variant
- MTHFR C677T (rs1801133) [folate & homocysteine] — functional variant
- FUT2 W143X (rs601338) [secretor status] — functional variant
- CUBN Phe253Ser (rs1801222) [cobalamin absorption] — functional variant
- TCN2 C776G (rs1801198) [vitamin B12 transport] — functional variant
- SLC23A1 rs33972313 [vitamin C] — functional variant
- BCO1 rs12934922 [carotenoid→vitamin A] — functional variant
- BCO1 rs7501331 [carotenoid→vitamin A] — functional variant
- CASR A986S (rs1801725) [calcium] — functional variant
- HFE H63D (rs1799945) [iron overload / hemochromatosis] — functional variant
- HFE C282Y (rs1800562) [iron overload / hemochromatosis] — functional variant
- TMPRSS6 V736A (rs855791) [iron status] — functional variant
- TF rs3811647 — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Electrolytes (combined profile) — composite score
- Iron status (combined profile) — composite score
4.3. Amino Acids
Number of indicators: 43 (36 complex indicators and 7 individual genetic variants).
Complex indicators — type: polygenic risk
Branched-chain amino acids (BCAA)
- Leucine — polygenic risk
- Isoleucine — polygenic risk
- Valine — polygenic risk
Other essential amino acids
- Histidine — polygenic risk
- Lysine — polygenic risk
- Methionine — polygenic risk
- Threonine — polygenic risk
- Tryptophan — polygenic risk
- Phenylalanine — polygenic risk
Conditionally essential amino acids
- Arginine — polygenic risk
- Glycine — polygenic risk
- Glutamine — polygenic risk
- Proline — polygenic risk
- Tyrosine — polygenic risk
- Cysteine — polygenic risk
Non-essential amino acids
- Alanine — polygenic risk
- Asparagine — polygenic risk
- Aspartate — polygenic risk
- Glutamate — polygenic risk
- Serine — polygenic risk
Urea cycle and methylated arginine derivatives
- Ornithine — polygenic risk
- Citrulline — polygenic risk
- Symmetric dimethylarginine (SDMA) — polygenic risk
Markers of one-carbon and related metabolism
- Homocysteine — polygenic risk
- Cystathionine — polygenic risk
- Betaine — polygenic risk
- Dimethylglycine (DMG) — polygenic risk
- Sarcosine — polygenic risk
- Methylmalonic acid (MMA) — polygenic risk
Tryptophan, kynurenine and other bioactive derivatives
- Kynurenine — polygenic risk
- Kynurenic acid — polygenic risk
- Taurine — polygenic risk
Creatine, muscle and structural metabolism
- Creatine — polygenic risk
- Guanidinoacetate — polygenic risk
- Beta-alanine — polygenic risk
Energy and enzyme markers
- Lactate — polygenic risk
Individual genetic variants — type: functional variant
- CPS1 Thr1406Asn (rs1047891) [glycine / urea cycle] — functional variant
- AGXT2 Val140Ile (rs37369) [methylated arginine / BP] — functional variant
- MTHFD1 Arg653Gln (rs2236225) [folate cycle] — functional variant
- MTHFR A1298C (rs1801131) [folate & homocysteine] — functional variant
- MTHFR C677T (rs1801133) [folate & homocysteine] — functional variant
- MTR Asp919Gly (rs1805087) [methionine synthase] — functional variant
- MTRR Ile22Met (rs1801394) [one-carbon metabolism] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Conditionally essential amino acids (combined profile) — composite score
4.4. Blood Biomarkers
Number of indicators: 52 (46 complex indicators and 6 individual genetic variants).
Complex indicators — type: polygenic risk
Red blood cells and red cell indices
- Hemoglobin — polygenic risk
- Red blood cell count (RBC) — polygenic risk
- Hematocrit (HCT) — polygenic risk
- Mean corpuscular volume (MCV) — polygenic risk
- Mean corpuscular hemoglobin (MCH) — polygenic risk
- Mean corpuscular hemoglobin concentration (MCHC) — polygenic risk
- Red cell distribution width (RDW) — polygenic risk
White blood cell profile
- White blood cell count (WBC) — polygenic risk
- Neutrophil count — polygenic risk
- Lymphocyte count — polygenic risk
- Monocyte count — polygenic risk
- Eosinophil count — polygenic risk
- Basophil count — polygenic risk
Platelets and coagulation
- Platelet count — polygenic risk
- Mean platelet volume (MPV) — polygenic risk
- Blood clotting — polygenic risk
Iron status
- Iron — polygenic risk
- Ferritin — polygenic risk
- Transferrin — polygenic risk
- Total iron-binding capacity — polygenic risk
- Transferrin saturation — polygenic risk
Circulating metabolic and lipid markers
- Total cholesterol — polygenic risk
- High-density lipoprotein (HDL) cholesterol — polygenic risk
- Very-low-density lipoprotein (VLDL) cholesterol — polygenic risk
- Apolipoprotein A-I — polygenic risk
- Lipoprotein(a) [Lp(a)] — polygenic risk
- Glycated hemoglobin — polygenic risk
- Uric acid — polygenic risk
Hematological conditions
- Anemia — polygenic risk
- Immune thrombocytopenia — polygenic risk
Liver markers and plasma proteins
- Alanine aminotransferase (ALT) — polygenic risk
- Aspartate aminotransferase (AST) — polygenic risk
- Alkaline phosphatase (ALP) — polygenic risk
- Bilirubin — polygenic risk
- Albumin — polygenic risk
Pancreatic and tissue enzyme markers
- Amylase — polygenic risk
- Lipase — polygenic risk
- Creatine kinase — polygenic risk
Thrombotic conditions
- Thromboembolism — polygenic risk
- Deep vein thrombosis — polygenic risk
- Venous thromboembolism — polygenic risk
- Thrombophilia — polygenic risk
- Phlebitis — polygenic risk
- Varicose veins — polygenic risk
Inflammation markers
- C-reactive protein — polygenic risk
- Fibrinogen — polygenic risk
Individual genetic variants — type: functional variant
- F2 G20210A (rs1799963) [thrombophilia] — functional variant
- F5 Leiden (rs6025) [thrombophilia] — functional variant
- FGB −455G>A (rs1800790) [fibrinogen] — functional variant
- TMPRSS6 V736A (rs855791) [iron status] — functional variant
- ABCG2 Q141K (rs2231142) [uric acid / gout] — functional variant
- IL6R Asp358Ala (rs2228145) [inflammation (IL-6)] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Red blood cell indices (combined profile) — composite score
- White blood cell profile (combined profile) — composite score
- Circulating metabolic & lipid markers (combined profile) — composite score
4.5. Lipids, Cholesterol and Fatty Acids
Number of indicators: 50 (33 complex indicators and 17 individual genetic variants).
Complex indicators — type: polygenic risk
Omega-3 fatty acids
- Alpha-linolenic acid (ALA) — polygenic risk
- Eicosapentaenoic acid (EPA) — polygenic risk
- Docosapentaenoic acid (DPA) — polygenic risk
- Docosahexaenoic acid (DHA) — polygenic risk
Omega-6 fatty acids and balance
- Omega-6 fatty acids — polygenic risk
- Linoleic acid (LA) — polygenic risk
- Gamma-linolenic acid (GLA) — polygenic risk
- Dihomo-gamma-linolenic acid (DGLA) — polygenic risk
- Arachidonic acid (ARA) — polygenic risk
- Omega-6/omega-3 ratio — polygenic risk
Fatty acid classes and chain length
- Saturated fatty acids (SFA) — polygenic risk
- Very-long-chain saturated fatty acids (VLC-SFA) — polygenic risk
- Monounsaturated fatty acids (MUFA) — polygenic risk
- Oleic acid — polygenic risk
Bioactive lipids and related compounds
- Coenzyme Q10 — polygenic risk
- Choline — polygenic risk
- Ceramide — polygenic risk
Cholesterol and triglyceride profile
- Total cholesterol — polygenic risk
- Low-density lipoprotein (LDL) cholesterol — polygenic risk
- High-density lipoprotein (HDL) cholesterol — polygenic risk
- Triglycerides — polygenic risk
- Non-HDL cholesterol — polygenic risk
- Very-low-density lipoprotein (VLDL) cholesterol — polygenic risk
- Remnant cholesterol — polygenic risk
Apolipoproteins and lipoprotein particles
- Apolipoprotein A-I — polygenic risk
- Apolipoprotein B (ApoB) — polygenic risk
- Apolipoprotein B-to-apolipoprotein A-I ratio — polygenic risk
- Lipoprotein(a) [Lp(a)] — polygenic risk
- HDL particle size — polygenic risk
- LDL particle size — polygenic risk
Lipid metabolism disorders
- Hyperlipidemia — polygenic risk
- Hypercholesterolemia — polygenic risk
- Hypertriglyceridemia — polygenic risk
Individual genetic variants — type: functional variant
- ELOVL2 rs953413 [long-chain PUFA-related phospholipid trait] — functional variant
- FADS1 rs174546 [blood lipids; PUFA desaturase locus] — functional variant
- FADS1/FADS2 locus rs174537 [omega-3/6 fatty acids] — functional variant
- FADS2 (rs174575) — functional variant
- ABCA1 R219K (rs2230806) — functional variant
- CETP TaqIB (rs708272) — functional variant
- LIPC −514C>T (rs1800588) — functional variant
- ANGPTL4 E40K (rs116843064) [triglycerides] — functional variant
- APOA5 S19W (rs3135506) [triglycerides] — functional variant
- APOA5 −1131T>C (rs662799) [triglycerides] — functional variant
- GCKR P446L (rs1260326) [triglycerides & metabolic traits] — functional variant
- LPL S447X (rs328) [triglycerides / HDL] — functional variant
- APOA2 −265T>C (rs5082) — functional variant
- APOE ε-haplotype (rs429358 + rs7412) — functional variant
- PCSK9 R46L (rs11591147) [LDL cholesterol] — functional variant
- LPA rs10455872 [lipoprotein(a)] — functional variant
- LPA rs3798220 [lipoprotein(a)] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Omega-6 fatty acids & balance (combined profile) — composite score
- Fatty acid classes & chain length (combined profile) — composite score
- Bioactive lipids & related compounds (combined profile) — composite score
- Cholesterol & triglyceride profile (combined profile) — composite score
- Apolipoproteins & lipoprotein particles (combined profile) — composite score
- Lipid disorders (combined risk) — composite score
4.6. Cardiovascular Health
Number of indicators: 46 (39 complex indicators and 7 individual genetic variants).
Complex indicators — type: polygenic risk
Blood pressure and autonomic regulation
- Systolic blood pressure — polygenic risk
- Diastolic blood pressure — polygenic risk
- Hypertension — polygenic risk
- Hypotension — polygenic risk
- Resting heart rate — polygenic risk
- Heart rate variability — polygenic risk
Cardiac electrical conduction
- PR interval — polygenic risk
- QRS complex duration — polygenic risk
- QT interval — polygenic risk
- Long QT syndrome — polygenic risk
- Arrhythmia — polygenic risk
- Atrial fibrillation — polygenic risk
- Bradycardia — polygenic risk
- Tachycardia — polygenic risk
Vascular stiffness and subclinical atherosclerosis
- Arterial stiffness index — polygenic risk
- Carotid intima-media thickness — polygenic risk
- Coronary artery calcification — polygenic risk
- Atherosclerosis — polygenic risk
Cardiomyopathies and inflammatory conditions
- Cardiomyopathy — polygenic risk
- Dilated cardiomyopathy — polygenic risk
- Pericarditis — polygenic risk
- Rheumatic heart disease — polygenic risk
- Vasculitis — polygenic risk
Aorta and heart valves
- Ascending thoracic aorta diameter — polygenic risk
- Descending thoracic aorta diameter — polygenic risk
- Aortic aneurysm — polygenic risk
- Aortic stenosis — polygenic risk
- Aortic valve calcification — polygenic risk
- Valvular heart disease — polygenic risk
Cerebrovascular events
- Stroke — polygenic risk
- Ischemic stroke — polygenic risk
- Cerebral aneurysm — polygenic risk
Coronary disease and acute cardiac events
- Coronary artery disease — polygenic risk
- Myocardial infarction — polygenic risk
- Early myocardial infarction — polygenic risk
Cardiac function and circulating biomarkers
- Left ventricular ejection fraction — polygenic risk
- Heart failure — polygenic risk
- N-terminal pro-B-type natriuretic peptide (NT-proBNP) — polygenic risk
- High-sensitivity cardiac troponin I — polygenic risk
Individual genetic variants — type: functional variant
- AGT Met268Thr (rs699) [blood pressure] — functional variant
- AGTR1 A1166C (rs5186) [angiotensin II receptor] — functional variant
- APOE ε-haplotype (rs429358 + rs7412) — functional variant
- PCSK9 R46L (rs11591147) [LDL cholesterol] — functional variant
- IL6R Asp358Ala (rs2228145) [inflammation (IL-6)] — functional variant
- LPA rs10455872 [lipoprotein(a)] — functional variant
- LPA rs3798220 [lipoprotein(a)] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Blood pressure & autonomic regulation (combined profile) — composite score
- Cardiac conduction (combined risk) — composite score
- Vascular stiffness & subclinical atherosclerosis (combined profile) — composite score
- Cardiomyopathy & inflammatory conditions (combined risk) — composite score
- Aorta & cardiac valves (combined profile) — composite score
4.7. Glucose and Metabolic Syndrome
Number of indicators: 51 (36 complex indicators and 15 individual genetic variants).
Complex indicators — type: polygenic risk
Glycemic biomarkers
- Fasting glucose — polygenic risk
- Glycated hemoglobin — polygenic risk
- Glucagon — polygenic risk
Insulin secretion and action
- Insulin — polygenic risk
- Proinsulin — polygenic risk
- HOMA-B (beta-cell function) — polygenic risk
- Insulin sensitivity — polygenic risk
Spectrum of carbohydrate metabolism disorders
- Prediabetes — polygenic risk
- Type 1 diabetes — polygenic risk
- Type 2 diabetes — polygenic risk
Overall fat mass
- Body mass index (BMI) — polygenic risk
- Body fat percentage — polygenic risk
- Overweight — polygenic risk
- Obesity — polygenic risk
Body composition (fat and muscle mass)
- Waist circumference — polygenic risk
- Hip circumference — polygenic risk
- Visceral fat — polygenic risk
- Liver fat fraction — polygenic risk
- Appendicular lean mass — polygenic risk
- Body-to-muscle mass ratio — polygenic risk
Adipokines
- Adiponectin — polygenic risk
- Leptin — polygenic risk
- Resistin — polygenic risk
Appetite regulation signals
- Appetite-regulating hormones — polygenic risk
- Ghrelin — polygenic risk
- The leptin receptor — polygenic risk
- Soluble leptin receptor — polygenic risk
- Peptide YY — polygenic risk
- Agouti-related peptide — polygenic risk
Metabolic conditions and urate
- Metabolic syndrome — polygenic risk
- Metabolic dysfunction-associated steatotic liver disease (MASLD, also known as fatty liver disease) — polygenic risk
- Uric acid — polygenic risk
- Gout — polygenic risk
Diabetic complications
- Diabetic neuropathy — polygenic risk
- Diabetic nephropathy — polygenic risk
- Diabetic retinopathy — polygenic risk
Individual genetic variants — type: functional variant
- KCNJ11 E23K (rs5219) [type 2 diabetes] — functional variant
- MTNR1B rs10830963 [glucose / diabetes] — functional variant
- SLC30A8 R325W (rs13266634) [type 2 diabetes] — functional variant
- TCF7L2 rs7903146 [type 2 diabetes] — functional variant
- GCKR P446L (rs1260326) [triglycerides & metabolic traits] — functional variant
- PPARG Pro12Ala (rs1801282) [type 2 diabetes] — functional variant
- ADRB3 Trp64Arg (rs4994) — functional variant
- PLIN1 11482G>A (rs1052700) — functional variant
- UCP1 −3826A>G (rs1800592) — functional variant
- UCP2 A55V (rs660339) — functional variant
- FTO rs9939609 [appetite / body weight] — functional variant
- MC4R (rs17782313) — functional variant
- PNPLA3 I148M (rs738409) [MASLD (fatty liver disease)] — functional variant
- TM6SF2 E167K (rs58542926) [MASLD (fatty liver disease)] — functional variant
- ABCG2 Q141K (rs2231142) [uric acid / gout] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Insulin secretion & action (combined profile) — composite score
- Body composition (adiposity & lean mass) (combined profile) — composite score
- Adipokines (combined profile) — composite score
- Metabolic states & urates (combined risk) — composite score
4.8. Liver, Gallbladder and Pancreas
Number of indicators: 38 (29 complex indicators and 9 individual genetic variants).
Complex indicators — type: polygenic risk
Liver enzymes and plasma proteins
- Alanine aminotransferase (ALT) — polygenic risk
- Aspartate aminotransferase (AST) — polygenic risk
- Gamma-glutamyl transferase (GGT) — polygenic risk
- Alkaline phosphatase (ALP) — polygenic risk
- Bilirubin — polygenic risk
- Albumin — polygenic risk
- Liver fat fraction — polygenic risk
- Liver iron content — polygenic risk
Metabolic liver disease
- Metabolic dysfunction-associated steatotic liver disease (MASLD, also known as fatty liver disease) — polygenic risk
- Metabolic dysfunction-associated steatohepatitis (MASH) — polygenic risk
- Alcohol-related liver disease — polygenic risk
Inflammatory and infectious liver disease
- Hepatitis B — polygenic risk
- Hepatitis C — polygenic risk
Fibrosis, cirrhosis and cholestasis
- Liver fibrosis — polygenic risk
- Liver cirrhosis — polygenic risk
- Reduced bile flow — polygenic risk
- Biliary cholangitis — polygenic risk
Gallbladder and bile duct conditions
- Gallstone disease — polygenic risk
- Cholecystitis — polygenic risk
- Sclerosing cholangitis — polygenic risk
Hepatobiliary cancers
- Liver cancer — polygenic risk
- Bile duct cancer — polygenic risk
- Gallbladder cancer — polygenic risk
Pancreatic function and disease
- Amylase — polygenic risk
- Lipase — polygenic risk
- Pancreatitis — polygenic risk
- Type 1 diabetes — polygenic risk
- Type 2 diabetes — polygenic risk
- Pancreatic cancer — polygenic risk
Individual genetic variants — type: functional variant
- HFE H63D (rs1799945) [iron overload / hemochromatosis] — functional variant
- HFE C282Y (rs1800562) [iron overload / hemochromatosis] — functional variant
- GSTP1 I105V (rs1695) — functional variant
- NQO1 P187S (rs1800566) — functional variant
- GCKR P446L (rs1260326) [triglycerides & metabolic traits] — functional variant
- MBOAT7 rs641738 [hepatic fat / lipid remodeling] — functional variant
- PNPLA3 I148M (rs738409) [MASLD (fatty liver disease)] — functional variant
- TM6SF2 E167K (rs58542926) [MASLD (fatty liver disease)] — functional variant
- ABCG8 D19H (rs11887534) [gallstones] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Liver enzymes & plasma proteins (combined profile) — composite score
4.9. Digestive System Health and Microbiome
Number of indicators: 26 (22 complex indicators and 4 individual genetic variants).
Complex indicators — type: polygenic risk
Esophagus and reflux conditions
- Esophageal disease — polygenic risk
- Gastroesophageal reflux disease — polygenic risk
- Barrett's esophagus — polygenic risk
- Esophageal cancer — polygenic risk
Stomach and peptic conditions
- Stomach disease — polygenic risk
- Gastritis — polygenic risk
- Peptic ulcer disease — polygenic risk
- Stomach ulcer — polygenic risk
- Duodenal ulcer — polygenic risk
- Stomach polyp — polygenic risk
- Nausea — polygenic risk
Bowel motility and function
- Irritable bowel syndrome (IBS) — polygenic risk
- Stool frequency — polygenic risk
- Constipation — polygenic risk
Inflammatory bowel disease
- Crohn's disease — polygenic risk
- Ulcerative colitis — polygenic risk
Immune-mediated and structural gut conditions
- Celiac disease — polygenic risk
- Malabsorption syndrome — polygenic risk
- Diverticular disease — polygenic risk
Microbiome, microbial exposure and gut barrier
- Gut microbiome variability — polygenic risk
- Gut permeability — polygenic risk
- Helicobacter pylori seropositivity — polygenic risk
Individual genetic variants — type: functional variant
- MCM6/LCT regulatory -13910C>T (rs4988235) [lactase persistence] — functional variant
- NOD2 R702W (rs2066844) [inflammatory bowel disease] — functional variant
- NOD2 G908R (rs2066845) [inflammatory bowel disease] — functional variant
- FUT2 W143X (rs601338) [secretor status] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Inflammatory bowel diseases (combined risk) — composite score
4.10. Kidneys and Urinary Tract
Number of indicators: 29 (23 complex indicators and 6 individual genetic variants).
Complex indicators — type: polygenic risk
Filtration and nitrogen metabolism
- Estimated glomerular filtration rate (eGFR) — polygenic risk
- Serum creatinine — polygenic risk
- Cystatin C — polygenic risk
- Serum urea — polygenic risk
- Albuminuria — polygenic risk
- Uromodulin — polygenic risk
Electrolytes, minerals and urate
- Serum sodium — polygenic risk
- Serum potassium — polygenic risk
- Chloride — polygenic risk
- Calcium — polygenic risk
- Phosphorus — polygenic risk
- Uric acid — polygenic risk
Glomerular and inflammatory conditions
- Glomerulonephritis — polygenic risk
- IgA nephropathy — polygenic risk
- Nephritis — polygenic risk
- Nephropathy — polygenic risk
- Nephrotic syndrome — polygenic risk
Kidney and urinary tract diseases
- Chronic kidney disease — polygenic risk
- Kidney failure — polygenic risk
- Polycystic kidney disease — polygenic risk
- Kidney stones — polygenic risk
- Urinary tract infections — polygenic risk
- Urinary frequency — polygenic risk
Individual genetic variants — type: functional variant
- SHROOM3 rs17319721 [eGFR / chronic kidney disease] — functional variant
- UMOD rs12917707 [eGFR / chronic kidney disease] — functional variant
- UMOD rs4293393 [kidney function] — functional variant
- CASR A986S (rs1801725) [calcium] — functional variant
- ABCG2 Q141K (rs2231142) [uric acid / gout] — functional variant
- SLC2A9 V253I (rs16890979) [uric acid] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Filtration & nitrogen metabolism (combined profile) — composite score
- Electrolytes, minerals & urates (combined profile) — composite score
4.11. Thyroid, Adrenal and Parathyroid
Number of indicators: 39 (25 complex indicators and 14 individual genetic variants).
Complex indicators — type: polygenic risk
Hormones and quantitative thyroid function
- Thyroid-stimulating hormone (TSH) — polygenic risk
- Free thyroxine (T4) — polygenic risk
- Free triiodothyronine (T3) — polygenic risk
- Free T3-to-free T4 ratio — polygenic risk
Thyroid disease
- Thyroid disease (general marker) — polygenic risk
- Hypothyroidism — polygenic risk
- Hyperthyroidism — polygenic risk
- Thyroiditis — polygenic risk
- Autoimmune thyroid disease — polygenic risk
- Hashimoto's thyroiditis — polygenic risk
- Graves' disease — polygenic risk
- Goiter — polygenic risk
- Thyroid nodules — polygenic risk
- Thyroid cancer — polygenic risk
Adrenal hormones and the stress response
- Morning cortisol — polygenic risk
- Dehydroepiandrosterone sulfate (DHEA-S) — polygenic risk
- Aldosterone — polygenic risk
- Renin or renin activity — polygenic risk
- Addison's disease — polygenic risk
Parathyroid glands, calcium and phosphate
- Parathyroid hormone (PTH) — polygenic risk
- Serum calcium — polygenic risk
- Serum phosphate — polygenic risk
- Bone mineral density — polygenic risk
- Hyperparathyroidism — polygenic risk
- Hypoparathyroidism — polygenic risk
Individual genetic variants — type: functional variant
- PDE8B rs4704397 [TSH / thyroid] — functional variant
- DIO1 rs2235544 [thyroid function] — functional variant
- DIO2 Thr92Ala (rs225014) [thyroid function] — functional variant
- CTLA4 rs3087243 [autoimmune thyroid] — functional variant
- PTPN22 R620W (rs2476601) [autoimmune] — functional variant
- TSHR rs12101261 [Graves disease susceptibility] — functional variant
- FOXE1 rs965513 [thyroid] — functional variant
- NKX2-1/PTCSC3 rs944289 [thyroid cancer] — functional variant
- HSD11B1 rs12086634 [cortisol] — functional variant
- NR3C1 rs6198 [cortisol receptor] — functional variant
- SERPINA6 rs12589136 [cortisol (CBG)] — functional variant
- CYP11B2 −344C>T (rs1799998) [aldosterone / BP] — functional variant
- CASR A986S (rs1801725) [calcium] — functional variant
- CYP24A1 rs6013897 [femoral-neck bone mineral density; vitamin-D pathway] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Thyroid conditions (combined risk) — composite score
- Parathyroid, calcium & phosphate (combined profile) — composite score
4.12. Reproductive, Growth and Metabolic Hormones
Number of indicators: 30 (22 complex indicators and 8 individual genetic variants).
Complex indicators — type: polygenic risk
Sex and reproductive hormones
- Luteinising hormone (LH) — polygenic risk
- Follicle-stimulating hormone (FSH) — polygenic risk
- Testosterone — polygenic risk
- Bioavailable testosterone — polygenic risk
- Oestradiol — polygenic risk
- Progesterone — polygenic risk
- 17-hydroxyprogesterone (17-OHP) — polygenic risk
- DHEA — polygenic risk
- Pregnenolone — polygenic risk
- Androgens — polygenic risk
- Sex hormone-binding globulin (SHBG) — polygenic risk
Pituitary function and the growth axis
- Insulin-like growth factor 1 (IGF-1) — polygenic risk
- Prolactin — polygenic risk
- Oxytocin — polygenic risk
Pancreatic endocrine function and glucose regulation
- Glycated hemoglobin (HbA1c) — polygenic risk
- Fasting glucose — polygenic risk
- Fasting insulin — polygenic risk
- C-peptide — polygenic risk
- Insulin resistance — polygenic risk
Appetite hormones and adipokines
- Ghrelin — polygenic risk
- Leptin — polygenic risk
- Adiponectin — polygenic risk
Individual genetic variants — type: functional variant
- SHBG rs1799941 [SHBG and testosterone concentration] — functional variant
- IGF1 rs35767 [growth / IGF-1] — functional variant
- IGF1R rs2229765 [IGF-1 signaling] — functional variant
- GCK −30G>A (rs1799884) [fasting glucose] — functional variant
- IRS1 rs2943641 [insulin resistance] — functional variant
- ADIPOQ rs266729 [adiponectin] — functional variant
- LEP −2548G>A (rs7799039) [leptin / appetite] — functional variant
- LEPR Q223R (rs1137101) [leptin receptor] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Sex & reproductive hormones (combined profile) — composite score
- Pancreatic endocrine & glucose regulation (combined profile) — composite score
- Appetite-regulating & adipokine hormones (combined profile) — composite score
4.13. Women's Health
Number of indicators: 71 (40 complex indicators and 31 individual genetic variants).
Complex indicators — type: polygenic risk
Reproductive period and ovarian aging
- Age at menarche — polygenic risk
- Age at natural menopause — polygenic risk
- Ovarian insufficiency — polygenic risk
- Vasomotor menopause symptoms — polygenic risk
Menstrual cycle and bleeding
- Menstrual cycle length — polygenic risk
- Heavy menstrual bleeding — polygenic risk
Ovarian conditions and endocrine disorders
- Polycystic ovary syndrome (PCOS) — polygenic risk
- Ovarian cyst — polygenic risk
- Ovarian dysfunction — polygenic risk
Fertility and ovarian reserve
- Female infertility — polygenic risk
- Time to pregnancy (fecundability) — polygenic risk
- Anti-Müllerian hormone (AMH) — polygenic risk
Uterine, cervical and pelvic health
- Uterine disease — polygenic risk
- Endometriosis — polygenic risk
- Uterine fibroids — polygenic risk
- Pelvic organ prolapse — polygenic risk
- HPV-associated cervical changes — polygenic risk
Pregnancy complications
- Gestational diabetes — polygenic risk
- Preeclampsia — polygenic risk
- Gestational thrombocytopenia — polygenic risk
- Preterm birth — polygenic risk
- Postpartum depression — polygenic risk
Hormonal markers of women's health
- Follicle-stimulating hormone (FSH) — polygenic risk
- Luteinising hormone (LH) — polygenic risk
- Oestradiol — polygenic risk
- Progesterone — polygenic risk
- Testosterone — polygenic risk
- Bioavailable testosterone — polygenic risk
- DHEA — polygenic risk
- Pregnenolone — polygenic risk
- Sex hormone-binding globulin (SHBG) — polygenic risk
- Oestrogen metabolism — polygenic risk
Predisposition to breast cancer and gynecological cancers
- Mammographic breast density — polygenic risk
- Breast cancer — polygenic risk
- Ovarian cancer — polygenic risk
- Endometrial cancer — polygenic risk
- Cervical cancer — polygenic risk
Bone health in the context of menopause
- Bone mineral density — polygenic risk
- Osteoporosis — polygenic risk
- Fractures — polygenic risk
Individual genetic variants — type: functional variant
- LIN28B rs314276 [age at menarche] — functional variant
- BRSK1 rs1172822 [menopause / ovarian reserve] — functional variant
- HELB rs75770066 [menopause / ovarian reserve] — functional variant
- MCM8 E341K (rs16991615) [menopause / ovarian reserve] — functional variant
- FSHB rs10835638 [reproductive hormones] — functional variant
- FSHB rs11031006 [reproductive hormones] — functional variant
- DENND1A rs2479106 [PMOS (polycystic ovary syndrome)] — functional variant
- FSHR rs2268361 [PMOS (PCOS) susceptibility locus] — functional variant
- LHCGR rs13405728 [PMOS (PCOS) susceptibility locus] — functional variant
- THADA rs13429458 [PMOS (polycystic ovary syndrome)] — functional variant
- GREB1 rs13394619 [endometriosis] — functional variant
- WNT4 rs7521902 [endometriosis] — functional variant
- BET1L rs2280543 [uterine fibroids] — functional variant
- TNRC6B rs12484776 [uterine fibroids / body-shape locus] — functional variant
- TERT rs2736100 [telomere / cancer] — functional variant
- TCF7L2 rs7903146 [type 2 diabetes] — functional variant
- FLT1-region rs4769613 [preeclampsia] — functional variant
- F2 G20210A (rs1799963) [thrombophilia] — functional variant
- F5 Leiden (rs6025) [thrombophilia] — functional variant
- ESR1 PvuII (rs2234693) [estrogen receptor] — functional variant
- ESR1 XbaI (rs9340799) [estrogen receptor] — functional variant
- COMT Val158Met (rs4680) [estrogen / dopamine] — functional variant
- CYP19A1 rs10046 [estrogen (aromatase)] — functional variant
- CYP1B1 Leu432Val (rs1056836) [estrogen metabolism] — functional variant
- BRCA1 (rs80357906) [hereditary breast/ovarian cancer] — functional variant
- BRCA1 (rs80357914) [hereditary breast/ovarian cancer] — functional variant
- BRCA2 (rs80359550) [hereditary breast/ovarian cancer] — functional variant
- CHEK2 I157T (rs17879961) [breast cancer risk] — functional variant
- FGFR2 rs2981582 [breast cancer] — functional variant
- TOX3 rs3803662 [breast cancer] — functional variant
- BNC2 (9p22) rs3814113 [ovarian cancer] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Uterine, cervical & pelvic health (combined risk) — composite score
- Female hormone biomarkers (combined profile) — composite score
4.14. Men's Health
Number of indicators: 34 (22 complex indicators and 12 individual genetic variants).
Complex indicators — type: polygenic risk
Male fertility and sperm quality
- Testicular disease — polygenic risk
Sexual function
- Erectile dysfunction — polygenic risk
- Sexual dysfunction — polygenic risk
- Sexual activity — polygenic risk
Prostate and lower urinary tract health
- Prostate disease — polygenic risk
- Benign prostatic hyperplasia with lower urinary tract symptoms — polygenic risk
- Prostatitis — polygenic risk
- Chronic prostatitis (chronic pelvic pain syndrome) — polygenic risk
- Prostate-specific antigen (PSA) — polygenic risk
Hormonal markers and androgen status
- Luteinising hormone (LH) — polygenic risk
- Follicle-stimulating hormone (FSH) — polygenic risk
- Testosterone — polygenic risk
- Bioavailable testosterone — polygenic risk
- Oestradiol — polygenic risk
- DHEA — polygenic risk
- Sex hormone-binding globulin (SHBG) — polygenic risk
- Male hypogonadism — polygenic risk
Age-related and androgen-dependent male traits
- Androgenetic alopecia in men — polygenic risk
- Facial and body hair growth — polygenic risk
- Timing of puberty in men — polygenic risk
Cancer risks in men's health
- Prostate cancer — polygenic risk
- Testicular germ cell tumor — polygenic risk
Individual genetic variants — type: functional variant
- FSHR Asn680Ser (rs6166) [reproductive hormones] — functional variant
- NOS3 Glu298Asp (rs1799983) [erectile function] — functional variant
- KLK3 I179T (rs17632542) [PSA / prostate] — functional variant
- KLK3 region rs2735839 [prostate cancer / PSA level] — functional variant
- KLK3 rs61752561 [PSA / prostate] — functional variant
- AR rs6152 [androgen receptor] — functional variant
- SRD5A2-region rs112881196 [androgens / hair] — functional variant
- SRD5A2 V89L (rs523349) [androgens (DHT)] — functional variant
- SPOCK1 rs1073917 [androgen-related] — functional variant
- BRCA2 (rs80359550) [hereditary breast/ovarian cancer] — functional variant
- HOXB13 G84E (rs138213197) [prostate cancer] — functional variant
- MSMB rs10993994 [prostate cancer] — functional variant
4.15. Cancer Risks
Number of indicators: 55 (35 complex indicators and 20 individual genetic variants).
Complex indicators — type: polygenic risk
Skin cancers
- Basal cell carcinoma — polygenic risk
- Squamous cell carcinoma of the skin — polygenic risk
- Melanoma — polygenic risk
Genitourinary cancers
- Bladder cancer — polygenic risk
- Kidney cancer — polygenic risk
Digestive tract cancers
- Colorectal cancer — polygenic risk
- Colon cancer — polygenic risk
- Rectal cancer — polygenic risk
- Stomach cancer — polygenic risk
- Esophageal cancer — polygenic risk
Hepatobiliary cancers and pancreatic cancer
- Pancreatic cancer — polygenic risk
- Liver cancer — polygenic risk
- Bile duct cancer — polygenic risk
- Gallbladder cancer — polygenic risk
Respiratory system cancers
- Lung cancer — polygenic risk
- Lung adenocarcinoma — polygenic risk
- Non-small cell lung cancer — polygenic risk
Hematologic malignancies
- Leukemia — polygenic risk
- Hodgkin lymphoma — polygenic risk
- Non-Hodgkin lymphoma — polygenic risk
- Multiple myeloma — polygenic risk
Central nervous system and eye tumors
- Glioma — polygenic risk
- Glioblastoma — polygenic risk
- Oligodendroglioma — polygenic risk
- Meningioma — polygenic risk
- Neuroblastoma — polygenic risk
- Eye cancer — polygenic risk
Endocrine and neuroendocrine tumors
- Thyroid cancer — polygenic risk
- Neuroendocrine tumor — polygenic risk
Bone and soft tissue cancers
- Bone cancer (osteosarcoma) — polygenic risk
- Sarcoma — polygenic risk
Head, neck and upper digestive tract cancers
- Head and neck cancer — polygenic risk
- Oral cancer — polygenic risk
- Oropharyngeal cancer — polygenic risk
- Pharyngeal cancer — polygenic risk
Individual genetic variants — type: functional variant
- MC1R R151C (rs1805007) [skin/hair pigmentation] — functional variant
- MC1R R160W (rs1805008) [skin/hair pigmentation] — functional variant
- TERT rs2736100 [telomere / cancer] — functional variant
- NAT2 rs1495741 [carcinogen detox / bladder] — functional variant
- TERT rs2736098 [telomerase locus; prostate and other cancers] — functional variant
- 8q24 rs6983267 [colorectal / prostate cancer] — functional variant
- APC I1307K (rs1801155) [colorectal cancer] — functional variant
- MUTYH Y179C (rs34612342) [colorectal polyposis] — functional variant
- MUTYH G396D (rs36053993) [colorectal polyposis] — functional variant
- SMAD7 rs4939827 [colorectal cancer] — functional variant
- PSCA rs2294008 [gastric cancer] — functional variant
- PSCA rs2976392 [diffuse-type gastric cancer] — functional variant
- BRCA1 (rs80357906) [hereditary breast/ovarian cancer] — functional variant
- BRCA1 (rs80357914) [hereditary breast/ovarian cancer] — functional variant
- BRCA2 (rs80359550) [hereditary breast/ovarian cancer] — functional variant
- CHEK2 I157T (rs17879961) [breast cancer risk] — functional variant
- EPAS1 rs11894252 [hypoxia / cancer] — functional variant
- NR5A2 rs3790844 [pancreatic cancer] — functional variant
- CHRNA5 D398N (rs16969968) [nicotine dependence] — functional variant
- FOXE1 rs965513 [thyroid] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Skin cancers (combined risk) — composite score
- Central nervous system & eye tumors (combined risk) — composite score
4.16. Allergies and Intolerances
Number of indicators: 28 (17 complex indicators and 11 individual genetic variants).
Complex indicators — type: polygenic risk
General allergic predisposition and biomarkers
- Allergic sensitization — polygenic risk
- Total serum immunoglobulin E (IgE) — polygenic risk
- Food allergy — polygenic risk
- Eosinophil count — polygenic risk
Respiratory and inhalant allergies
- Allergic rhinitis — polygenic risk
- Asthma — polygenic risk
- Sensitization to animal allergens — polygenic risk
- Cat allergy — polygenic risk
- Dog allergy — polygenic risk
Food intolerances and immune-mediated reactions
- Lactase persistence — polygenic risk
- Fructose metabolism and absorption — polygenic risk
- Celiac disease — polygenic risk
- Peanut allergy — polygenic risk
- Egg allergy — polygenic risk
Skin and contact allergies
- Atopic dermatitis — polygenic risk
- Allergic contact dermatitis — polygenic risk
- Angioedema — polygenic risk
Individual genetic variants — type: functional variant
- IL13 rs1800925 [atopic dermatitis / skin barrier] — functional variant
- TSLP rs1837253 [asthma / allergy] — functional variant
- FCER1A rs2251746 [IgE / allergy] — functional variant
- IL13 rs20541 [allergy / IgE] — functional variant
- IL4R rs1801275 [allergy / IgE] — functional variant
- MCM6/LCT regulatory -13910C>T (rs4988235) [lactase persistence] — functional variant
- SERPINB cluster rs12964116 [food allergy] — functional variant
- AOC1 rs10156191 [histamine metabolism] — functional variant
- AOC1 rs1049742 [histamine metabolism] — functional variant
- AOC1 rs2052129 [histamine metabolism] — functional variant
- HNMT rs11558538 [histamine metabolism] — functional variant
4.17. Immunity, Infections and Autoimmune Conditions
Number of indicators: 57 (41 complex indicators and 16 individual genetic variants).
Complex indicators — type: polygenic risk
Systemic autoimmune conditions
- Autoimmune disease (general marker) — polygenic risk
- Systemic autoimmune connective tissue disease — polygenic risk
- Systemic lupus erythematosus — polygenic risk
- Rheumatoid arthritis — polygenic risk
- Systemic sclerosis — polygenic risk
- Sjögren's syndrome — polygenic risk
- Behçet's disease — polygenic risk
- Sarcoidosis — polygenic risk
- Antiphospholipid syndrome — polygenic risk
Organ-specific autoimmune conditions
- Type 1 diabetes — polygenic risk
- Autoimmune thyroid disease — polygenic risk
- Graves' disease — polygenic risk
- Celiac disease — polygenic risk
- Multiple sclerosis — polygenic risk
- Myasthenia gravis — polygenic risk
- Biliary cholangitis — polygenic risk
- Sclerosing cholangitis — polygenic risk
Inflammatory bowel disease
- Crohn's disease — polygenic risk
- Ulcerative colitis — polygenic risk
Immune-mediated skin and joint conditions
- Psoriasis — polygenic risk
- Psoriatic arthritis — polygenic risk
- Atopic dermatitis — polygenic risk
- Ankylosing spondylitis — polygenic risk
Bacterial and urinary infections
- Tuberculosis — polygenic risk
- Pneumonia — polygenic risk
- Meningitis — polygenic risk
- Urinary tract infections — polygenic risk
- Clostridioides difficile infection — polygenic risk
Viral infections and severity of illness
- Hepatitis B — polygenic risk
- Hepatitis C — polygenic risk
- Shingles — polygenic risk
- HIV infection and AIDS progression — polygenic risk
- Mumps — polygenic risk
- Severe COVID-19 — polygenic risk
Other infections and debated phenotypes
- Lyme disease — polygenic risk
Immune and inflammatory biomarkers
- Neutrophil count — polygenic risk
- Monocyte count — polygenic risk
- Eosinophil count — polygenic risk
- Basophil count — polygenic risk
- Total serum immunoglobulin E (IgE) — polygenic risk
- C-reactive protein — polygenic risk
Individual genetic variants — type: functional variant
- CTLA4 rs3087243 [autoimmune thyroid] — functional variant
- PTPN22 R620W (rs2476601) [autoimmune] — functional variant
- STAT4 rs7574865 [autoimmune] — functional variant
- TNFAIP3 rs2230926 [autoimmune] — functional variant
- IL2RA rs2104286 [autoimmune] — functional variant
- IL7R rs6897932 [multiple sclerosis / autoimmune] — functional variant
- ATG16L1 T300A (rs2241880) [Crohn’s disease] — functional variant
- IL23R R381Q (rs11209026) [psoriasis / IBD] — functional variant
- NOD2 R702W (rs2066844) [inflammatory bowel disease] — functional variant
- NOD2 G908R (rs2066845) [inflammatory bowel disease] — functional variant
- TRAF3IP2 rs33980500 [psoriasis] — functional variant
- FCGR2A His167Arg (rs1801274) [ulcerative colitis / IBD] — functional variant
- TLR4 Asp299Gly (rs4986790) [innate immune receptor; curated] — functional variant
- DPP9 rs2109069 [severe COVID-19] — functional variant
- LZTFL1 locus rs73064425 [severe COVID-19] — functional variant
- OAS1 rs10774671 [severe COVID-19] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Systemic autoimmune conditions (combined risk) — composite score
- Organ-specific autoimmune conditions (combined risk) — composite score
- Immune-mediated skin & joint conditions (combined risk) — composite score
- Immune and inflammatory biomarkers (combined profile) — composite score
4.18. Respiratory System Health
Number of indicators: 22 (16 complex indicators and 6 individual genetic variants).
Complex indicators — type: polygenic risk
Lung function
- Forced expiratory volume in one second (FEV₁) — polygenic risk
- Forced vital capacity (FVC) — polygenic risk
- FEV₁/FVC ratio — polygenic risk
- Peak expiratory flow — polygenic risk
Lower airway conditions
- Asthma — polygenic risk
- Chronic obstructive pulmonary disease (COPD) — polygenic risk
- Chronic bronchitis — polygenic risk
- Chronic mucus hypersecretion — polygenic risk
Upper airways and sinuses
- Allergic rhinitis — polygenic risk
- Chronic rhinosinusitis — polygenic risk
- Nasal polyps — polygenic risk
- Sinus congestion — polygenic risk
Interstitial, infectious and sleep-related respiratory conditions
- Pneumonia — polygenic risk
- Obstructive sleep apnea — polygenic risk
- Interstitial lung disease — polygenic risk
- Idiopathic pulmonary fibrosis — polygenic risk
Individual genetic variants — type: functional variant
- CHRNA3 rs1051730 [nicotine / lung] — functional variant
- FAM13A rs7671167 [COPD / lung function] — functional variant
- HHIP rs13118928 [COPD / lung function] — functional variant
- GSDMB rs7216389 [asthma] — functional variant
- IL33 rs1342326 [asthma] — functional variant
- MUC5B rs35705950 [pulmonary fibrosis] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Lower-airway conditions (combined risk) — composite score
4.19. Mental Health and Personality
Number of indicators: 39 (38 complex indicators and 1 individual genetic variant).
Complex indicators — type: polygenic risk
Affective and psychotic conditions
- Depression — polygenic risk
- Bipolar disorder — polygenic risk
- Mania — polygenic risk
- Mood instability — polygenic risk
- Schizophrenia — polygenic risk
- Psychosis — polygenic risk
Anxiety and traumatic stress
- Anxiety — polygenic risk
- Panic attacks — polygenic risk
- Social anxiety — polygenic risk
- Worry proneness — polygenic risk
- Post-traumatic stress disorder (PTSD) — polygenic risk
Obsessive-compulsive spectrum
- Obsessive-compulsive disorder (OCD) — polygenic risk
- Hoarding symptoms — polygenic risk
Personality disorders
- Antisocial personality disorder — polygenic risk
- Borderline personality disorder — polygenic risk
- Personality disorder — polygenic risk
Emotional reactivity
- Anger — polygenic risk
- Irritability — polygenic risk
- Nervousness — polygenic risk
Predisposition to self-harm
- Self-harm — polygenic risk
- Suicidal ideation — polygenic risk
- Suicide attempts — polygenic risk
- Social interaction — polygenic risk
Selected Big Five traits
- Conscientiousness — polygenic risk
- Extraversion — polygenic risk
- Neuroticism — polygenic risk
Creativity and social functioning
- Creativity — polygenic risk
- Loneliness — polygenic risk
- Social interaction — polygenic risk
Positive psychological well-being
- Subjective well-being — polygenic risk
- Life satisfaction — polygenic risk
- Positive affect — polygenic risk
- Optimism — polygenic risk
Risk-taking predisposition
- Boldness in decision-making — polygenic risk
- Self-reported risky decisions — polygenic risk
- Adventurousness — polygenic risk
Neurotransmitter signaling
- Dopamine — polygenic risk
- Serotonin — polygenic risk
Individual genetic variants — type: functional variant
- BDNF Val66Met (rs6265) [neurotrophin; BMI and behavioral traits] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Mood & psychotic disorders (combined risk) — composite score
4.20. Sleep and Circadian Rhythms
Number of indicators: 26 (18 complex indicators and 8 individual genetic variants).
Complex indicators — type: polygenic risk
Sleep duration and timing
- Sleep duration — polygenic risk
Sleep quality and architecture
- Sleep quality — polygenic risk
- Sleep latency — polygenic risk
- Sleep depth — polygenic risk
- NREM sleep duration — polygenic risk
- REM sleep duration — polygenic risk
Sleep continuity and fragmentation
- Wake after sleep onset — polygenic risk
Sleep disturbances
- Insomnia — polygenic risk
- Obstructive sleep apnea — polygenic risk
- Snoring — polygenic risk
- Restless legs syndrome — polygenic risk
- Movement during sleep — polygenic risk
- REM sleep behavior disorder — polygenic risk
- Sleepwalking (somnambulism) — polygenic risk
Circadian features and daytime sleep
- Chronotype — polygenic risk
- Daytime sleepiness — polygenic risk
- Daytime napping — polygenic risk
- Caffeine-related sleep disturbance — polygenic risk
Individual genetic variants — type: functional variant
- ADA rs73598374 [sleep depth] — functional variant
- ADORA2A rs5751876 [caffeine / sleep] — functional variant
- MEIS1 rs113851554 [restless legs] — functional variant
- CLOCK 3111T>C (rs1801260) [circadian rhythm] — functional variant
- PAX8-region / LINC02966 rs62158211 [sleep duration] — functional variant
- RGS16 H137R (rs1144566) [chronotype] — functional variant
- RGS16-region rs12736689 [chronotype] — functional variant
- VIP-region rs9479402 [chronotype] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Sleep quality & architecture (combined profile) — composite score
- Circadian rhythm & daytime sleep (combined profile) — composite score
4.21. Addictions and Behavior
Number of indicators: 33 (25 complex indicators and 8 individual genetic variants).
Complex indicators — type: polygenic risk
Alcohol consumption and physiological response
- Alcohol consumption — polygenic risk
- Number of alcoholic drinks per week — polygenic risk
Smoking and nicotine behavior
- Smoking — polygenic risk
- Onset of regular smoking — polygenic risk
- Cigarettes per day — polygenic risk
- Likelihood of quitting smoking — polygenic risk
- Nicotine and alcohol co-dependence — polygenic risk
Cannabis and other psychoactive substances
- Substance use disorder — polygenic risk
- Cannabis dependence — polygenic risk
Addictions and risk-taking behavior
- Addiction (general marker) — polygenic risk
- Internet addiction — polygenic risk
- Risk-taking behavior — polygenic risk
Consumption behavior and lifestyle
- Caffeine consumption — polygenic risk
- Sedentary work pattern — polygenic risk
Eating disorders
- Eating disorders — polygenic risk
- Anorexia nervosa — polygenic risk
- Bulimia nervosa — polygenic risk
- Binge eating — polygenic risk
Macronutrient intake and eating habits
- Carbohydrate intake — polygenic risk
- Sugar intake — polygenic risk
- Sweet cravings — polygenic risk
- Fatty food intake — polygenic risk
Chemosensory perception (taste and smell)
- Bitter taste — polygenic risk
- Sweet taste — polygenic risk
- Sense of smell — polygenic risk
Individual genetic variants — type: functional variant
- ADH1B Arg48His (rs1229984) [alcohol metabolism] — functional variant
- ALDH2 Glu504Lys (rs671) [alcohol metabolism] — functional variant
- CHRNA5 D398N (rs16969968) [nicotine dependence] — functional variant
- CYP1A2 rs762551 [caffeine metabolism] — functional variant
- TAS2R38 PAV/AVI haplotype [bitter taste] — functional variant
- TAS2R38 I296V (rs10246939) [bitter taste] — functional variant
- TAS2R38 V262A (rs1726866) [bitter taste] — functional variant
- TAS2R38 A49P (rs713598) [bitter taste] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Smoking & nicotine behavior (combined profile) — composite score
4.22. Eye and Ear Health
Number of indicators: 42 (35 complex indicators and 7 individual genetic variants).
Complex indicators — type: polygenic risk
Refraction and eye shape
- Refractive error — polygenic risk
- Nearsightedness — polygenic risk
- Farsightedness — polygenic risk
- Astigmatism — polygenic risk
- Corneal astigmatism — polygenic risk
- Axial eye length — polygenic risk
Anterior segment and intraocular pressure
- Intraocular pressure — polygenic risk
- Glaucoma — polygenic risk
- Central corneal thickness — polygenic risk
- Corneal hysteresis — polygenic risk
- Keratoconus — polygenic risk
- Cataracts — polygenic risk
- Conjunctivitis — polygenic risk
- Dry eye disease — polygenic risk
- Eye inflammation — polygenic risk
- Uveitis — polygenic risk
Retina and optic nerve
- Age-related macular degeneration (AMD) — polygenic risk
- Diabetic retinopathy — polygenic risk
- Retinal nerve fiber layer thickness — polygenic risk
- Ganglion cell and inner plexiform layer thickness — polygenic risk
- Retinal vessel caliber — polygenic risk
- Retinal vessel fractal density — polygenic risk
Visual function and other eye conditions
- Eye disease — polygenic risk
- Visual acuity — polygenic risk
- Contrast sensitivity — polygenic risk
- Pseudoexfoliation syndrome — polygenic risk
- Exfoliative glaucoma — polygenic risk
Hearing and auditory function
- Hearing loss — polygenic risk
- Age-related hearing decline in adulthood — polygenic risk
- Difficulty hearing in background noise — polygenic risk
Inner ear and balance disorders
- Tinnitus — polygenic risk
- Vertigo (benign paroxysmal positional vertigo, BPPV) — polygenic risk
- Ménière's disease — polygenic risk
Middle and outer ear
- Middle ear disease (otitis media) — polygenic risk
- Otosclerosis — polygenic risk
Individual genetic variants — type: functional variant
- SIX6 His141Asn (rs33912345) [glaucoma / intraocular pressure] — functional variant
- LOXL1 R141L (rs1048661) [exfoliation glaucoma] — functional variant
- LOXL1 G153D (rs3825942) [exfoliation glaucoma] — functional variant
- ARMS2 A69S (rs10490924) [macular degeneration] — functional variant
- CFH Y402H (rs1061170) [macular degeneration] — functional variant
- HTRA1 rs11200638 [age-related macular degeneration] — functional variant
- ABCC11 Gly180Arg (rs17822931) [earwax type / axillary odor] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Refraction & ocular shape (combined risk) — composite score
- Anterior segment & intraocular pressure (combined risk) — composite score
- Retina & optic nerve (combined profile) — composite score
4.23. Dental and Oral Health
Number of indicators: 35 (29 complex indicators and 6 individual genetic variants).
Complex indicators — type: polygenic risk
Teeth: development, cavities and enamel
- Cavities — polygenic risk
- Enamel hypoplasia — polygenic risk
- Number of teeth in adulthood — polygenic risk
- Timing of baby tooth eruption — polygenic risk
- Number of baby teeth — polygenic risk
Gums, periodontium and oral microbiome
- Gum disease — polygenic risk
- Periodontitis — polygenic risk
- A combined genetic score for periodontitis and tooth mobility (MTAG) — polygenic risk
- Average clinical attachment loss — polygenic risk
- Bleeding gums — polygenic risk
- Composition of the oral microbiome — polygenic risk
Jaw, bite and orofacial pain
- Temporomandibular joint pain disorder — polygenic risk
- Chronic pain — polygenic risk
- Migraine — polygenic risk
Oral and pharyngeal cancers
- Oral cancer — polygenic risk
- Oropharyngeal cancer — polygenic risk
- Pharyngeal cancer — polygenic risk
Nutrients related to dental and gum tissue
- Vitamin D (25(OH)D) — polygenic risk
- Phylloquinone (vitamin K1) — polygenic risk
- Vitamin C — polygenic risk
- Folate (vitamin B9) — polygenic risk
- Calcium — polygenic risk
- Phosphorus — polygenic risk
- Magnesium — polygenic risk
- Zinc — polygenic risk
- Iron — polygenic risk
Systemic links to oral health
- Bone density — polygenic risk
- Rheumatoid arthritis — polygenic risk
- Sjögren's syndrome — polygenic risk
Individual genetic variants — type: functional variant
- CACNB2 rs10740993 [primary tooth eruption] — functional variant
- KCNJ2 rs8080944 [primary tooth eruption] — functional variant
- IL1A rs1800587 [periodontitis] — functional variant
- IL1B rs1143634 [periodontitis] — functional variant
- MMP3 rs679620 [periodontitis] — functional variant
- FUT2 W143X (rs601338) [secretor status] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Nutrients linked to teeth & gums (combined profile) — composite score
4.24. Skin, Hair and Appearance
Number of indicators: 51 (36 complex indicators and 15 individual genetic variants).
Complex indicators — type: polygenic risk
Structure and visible skin aging
- Skin aging — polygenic risk
- Facial photoaging — polygenic risk
- Skin elasticity — polygenic risk
- Skin hydration — polygenic risk
Circulating matrix proteins and growth factors
- Decorin — polygenic risk
- Fibronectin — polygenic risk
- Laminin — polygenic risk
- Epidermal growth factor — polygenic risk
Barrier, dryness and skin sensitivity
- Skin barrier function — polygenic risk
- Filaggrin-dependent skin barrier homeostasis — polygenic risk
- Dry skin — polygenic risk
- Skin sensitivity to sunlight — polygenic risk
Pigmentation, sun response and moles
- Facial skin pigmentation — polygenic risk
- Tanning response — polygenic risk
- Freckles — polygenic risk
- Melanocytic nevi — polygenic risk
Acne, pores and pilosebaceous unit health
- Pilosebaceous unit disorders — polygenic risk
- Acne — polygenic risk
- Rosacea — polygenic risk
- Vascular skin disorders — polygenic risk
Inflammatory, allergic and infectious skin conditions
- Skin disease — polygenic risk
- Atopic dermatitis — polygenic risk
- Eczema — polygenic risk
- Hand eczema — polygenic risk
- Psoriasis — polygenic risk
- Allergic contact dermatitis — polygenic risk
- Dermatophytosis — polygenic risk
- Dermatomyositis — polygenic risk
Hair growth, thickness and loss
- Hair thickness — polygenic risk
- Hair graying — polygenic risk
- Facial and body hair growth — polygenic risk
- Alopecia areata — polygenic risk
Skin cancer risks
- Skin cancer — polygenic risk
- Melanoma — polygenic risk
- Basal cell carcinoma — polygenic risk
- Squamous cell carcinoma of the skin — polygenic risk
Individual genetic variants — type: functional variant
- COL1A1 rs1800012 [bone / connective tissue] — functional variant
- ELN rs2071307 [skin elastin] — functional variant
- ASIP-region rs4911414 [pigmentation] — functional variant
- HERC2/OCA2 rs12913832 [eye/hair color] — functional variant
- MC1R R151C (rs1805007) [skin/hair pigmentation] — functional variant
- MC1R R160W (rs1805008) [skin/hair pigmentation] — functional variant
- SLC24A5 A111T (rs1426654) [skin pigmentation] — functional variant
- SLC45A2 L374F (rs16891982) [pigmentation] — functional variant
- TYR S192Y (rs1042602) [pigmentation] — functional variant
- MC1R Asp294His (rs1805009) [melanoma / UV sensitivity] — functional variant
- IRF4 rs12203592 [pigmentation / greying] — functional variant
- IL13 rs20541 [allergy / IgE] — functional variant
- IL23R R381Q (rs11209026) [psoriasis / IBD] — functional variant
- SRD5A2-region rs112881196 [androgens / hair] — functional variant
- MITF E318K (rs149617956) [melanoma] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Inflammatory, allergic & infectious skin conditions (combined risk) — composite score
4.25. Musculoskeletal System, Injury and Recovery
Number of indicators: 37 (22 complex indicators and 15 individual genetic variants).
Complex indicators — type: polygenic risk
Muscle mass and function
- Muscle strength — polygenic risk
- Muscle volume — polygenic risk
- Appendicular lean mass — polygenic risk
- Thigh muscle fat infiltration — polygenic risk
- Muscle mass loss — polygenic risk
- Sarcopenia — polygenic risk
Bone density and fracture risk
- Bone mineral density — polygenic risk
- Osteoporosis — polygenic risk
- Fractures — polygenic risk
Joint health
- Osteoarthritis — polygenic risk
- Joint pain — polygenic risk
- Joint stiffness — polygenic risk
- Knee pain — polygenic risk
- Adhesive capsulitis of the shoulder — polygenic risk
Spine and back health
- Lumbar intervertebral disc degeneration — polygenic risk
- Lumbar disc herniation — polygenic risk
- Lumbar spinal stenosis — polygenic risk
Tendons, ligaments and tunnel syndromes
- Tendinopathy — polygenic risk
- Achilles tendon injury — polygenic risk
- Ankle injury — polygenic risk
- Dupuytren's contracture — polygenic risk
- Carpal tunnel syndrome — polygenic risk
Individual genetic variants — type: functional variant
- LRP5 rs3736228 [bone density] — functional variant
- VDR rs1544410 [vitamin D] — functional variant
- VDR FokI (rs2228570) [vitamin D] — functional variant
- VDR rs7975232 [vitamin D] — functional variant
- WNT16 rs2707466 [bone density] — functional variant
- WNT16 rs2908004 [bone density] — functional variant
- GDF5 rs143383 [osteoarthritis / joints] — functional variant
- GDF5 rs143384 [osteoarthritis / joints] — functional variant
- TGFA rs958685 [joint / cleft] — functional variant
- COL1A1 rs1107946 [bone / connective tissue] — functional variant
- COL1A1 rs1800012 [bone / connective tissue] — functional variant
- COL5A1 rs12722 [tendon / ligament] — functional variant
- TNC rs1138545 [tendon] — functional variant
- TNC rs7021589 [tendon] — functional variant
- TNC rs72758637 [tendon] — functional variant
4.26. Athletic Potential and Physical Performance
Number of indicators: 25 (13 complex indicators and 12 individual genetic variants).
Complex indicators — type: polygenic risk
Aerobic capacity and recovery
- Cardiorespiratory endurance (VO₂max) — polygenic risk
- Heart rate response to exercise — polygenic risk
- Heart-rate recovery after exercise — polygenic risk
- Resting heart rate — polygenic risk
- Heart rate variability — polygenic risk
Strength and body composition
- Muscle fiber type — polygenic risk
Exercise biomarkers
- Lactate — polygenic risk
- Creatine — polygenic risk
- Serum creatine kinase — polygenic risk
Physical activity patterns
- Physical activity — polygenic risk
- Usual walking pace — polygenic risk
Reaction and information-processing speed
- Reaction time — polygenic risk
- Information-processing speed — polygenic risk
Individual genetic variants — type: functional variant
- ACE I/D (rs1799752) [endurance] — functional variant
- PPARA rs4253778 [lipid oxidation / endurance] — functional variant
- PPARGC1A rs8192678 [mitochondrial / endurance] — functional variant
- ACTN3 R577X (rs1815739) [muscle fiber / sprint] — functional variant
- AMPD1 rs17602729 [muscle energy metabolism] — functional variant
- GCKR P446L (rs1260326) [triglycerides & metabolic traits] — functional variant
- SLC16A1/MCT1 rs1049434 [lactate transport] — functional variant
- CKM rs8111989 [muscle creatine kinase] — functional variant
- UCP3 −55C>T (rs1800849) — functional variant
- ADRB2 rs1042713 [bronchi / metabolism] — functional variant
- ADRB2 rs1042714 [bronchi / metabolism] — functional variant
- PPP1R3B rs9987289 [glycogen metabolism] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Aerobic capacity & recovery (combined profile) — composite score
4.27. Longevity and Biological Aging
Number of indicators: 53 (35 complex indicators and 18 individual genetic variants).
Complex indicators — type: polygenic risk
Lifespan, healthspan and integrated aging
- Exceptional longevity — polygenic risk
- Healthspan — polygenic risk
- Pace of aging — polygenic risk
Molecular and cellular aging
- Telomere length — polygenic risk
- Epigenetic age acceleration — polygenic risk
- The Klotho protein — polygenic risk
- Catalase — polygenic risk
- Superoxide dismutase activity — polygenic risk
- Thioredoxin — polygenic risk
Physical vulnerability, mobility and resilience
- Frailty index — polygenic risk
- Muscle mass loss — polygenic risk
- Sarcopenia — polygenic risk
- Reduced grip strength in older age — polygenic risk
- Usual walking pace — polygenic risk
- Physical activity — polygenic risk
- Orthostatic hypotension — polygenic risk
Brain and cognitive aging
- Cognitive decline — polygenic risk
- Episodic memory — polygenic risk
- Short-term memory — polygenic risk
- Processing speed — polygenic risk
- Reaction time — polygenic risk
- Dementia — polygenic risk
- Alzheimer's disease — polygenic risk
- Frontotemporal dementia — polygenic risk
- Dementia with Lewy bodies — polygenic risk
- Parkinson's disease — polygenic risk
Sensory aging
- Cataracts — polygenic risk
- Age-related macular degeneration — polygenic risk
- Age-related hearing loss — polygenic risk
Bone aging and fractures
- Bone mineral density — polygenic risk
- Osteoporosis — polygenic risk
- Fractures — polygenic risk
- Hip fracture — polygenic risk
Reproductive and visible markers of aging
- Skin aging — polygenic risk
- Hair graying — polygenic risk
Individual genetic variants — type: functional variant
- FOXO3 rs2802292 [longevity] — functional variant
- CDKN2B-AS1 rs4977574 [cardiometabolic / aging] — functional variant
- CHRNA5 D398N (rs16969968) [nicotine dependence] — functional variant
- OBFC1/STN1 rs9420907 [telomere length] — functional variant
- POLD3 rs11236203 [telomere length] — functional variant
- RTEL1 rs755017 [telomere length] — functional variant
- TERC-region rs10936599 [telomere length] — functional variant
- KL-VS / KLOTHO F352V (rs9536314) [Klotho / longevity] — functional variant
- CAT −262C>T (rs1001179) [catalase / oxidative stress] — functional variant
- SOD2 Val16Ala (rs4880) [oxidative stress / aging] — functional variant
- GPX1 P198L (rs1050450) — functional variant
- GDF5 rs143384 [osteoarthritis / joints] — functional variant
- SLC39A8 A391T (rs13107325) [manganese / frailty] — functional variant
- TGFA rs958685 [joint / cleft] — functional variant
- ARMS2 A69S (rs10490924) [macular degeneration] — functional variant
- CFH Y402H (rs1061170) [macular degeneration] — functional variant
- TERT rs2736100 [telomere / cancer] — functional variant
- C3 R102G (rs2230199) [macular degeneration] — functional variant
Composite scores — type: composite score
Summary scores calculated from the indicators of this direction. They are provided in the Report in addition and are not included in the number of indicators stated above.
- Lifespan, healthspan & integrated aging (combined profile) — composite score
- Frailty, mobility & physical resilience (combined profile) — composite score
- Brain & cognitive aging (combined risk) — composite score
5. PANELS (COMPLETE SERVICES)
5.1. A Panel is a comprehensive Service that combines a DNA kit, laboratory analysis and the interpretation of several Tests in a single order at a reduced price. Each Panel includes a DNA kit and laboratory analysis.
5.2. Prisma
The "Prisma" Service is one Test of the Customer's choice out of the 26 Apixmed Prism directions. The number of indicators depends on the direction selected and ranges from 22 to 71 indicators (see clauses 4.2-4.27).
The composition includes:
- DNA kit (saliva collection + laboratory analysis + delivery)
- One Test of the Customer's choice
- Genetic report in PDF format
- Raw genetic data file
5.3. Wellness Panel
A comprehensive panel for assessing health, lifestyle and prevention — a universal starter set. It covers 5 Tests with a total of 220 unique indicators: 161 complex indicators and 59 individual genetic variants. The directions of the panel do not overlap — each indicator is included in it once.
The composition includes:
- DNA kit (saliva collection + laboratory analysis + delivery)
- "Vitamins and Micronutrients" Test — 58 indicators
- "Glucose and Metabolic Syndrome" Test — 51 indicators
- "Cardiovascular Health" Test — 46 indicators
- "Mental Health and Personality" Test — 39 indicators
- "Sleep and Circadian Rhythms" Test — 26 indicators
- Genetic report in PDF format
- Raw genetic data file
5.4. Ultima Panel
The full panel includes all directions of the Apixmed Prism programme. The panel covers 25 directions: the "Women's Health" and "Men's Health" directions are provided separately, and only one of the two is relevant for each Customer. The total scope is more than 1,000 indicators, including more than 720 complex indicators and more than 270 individual genetic variants.
The composition includes:
- DNA kit (saliva collection + laboratory analysis + delivery)
- "Vitamins and Micronutrients" Test — 58 indicators
- "Amino Acids" Test — 43 indicators
- "Blood Biomarkers" Test — 52 indicators
- "Lipids, Cholesterol and Fatty Acids" Test — 50 indicators
- "Cardiovascular Health" Test — 46 indicators
- "Glucose and Metabolic Syndrome" Test — 51 indicators
- "Liver, Gallbladder and Pancreas" Test — 38 indicators
- "Digestive System Health and Microbiome" Test — 26 indicators
- "Kidneys and Urinary Tract" Test — 29 indicators
- "Thyroid, Adrenal and Parathyroid" Test — 39 indicators
- "Reproductive, Growth and Metabolic Hormones" Test — 30 indicators
- "Women's Health" Test — 71 indicators
- "Men's Health" Test — 34 indicators
- "Cancer Risks" Test — 55 indicators
- "Allergies and Intolerances" Test — 28 indicators
- "Immunity, Infections and Autoimmune Conditions" Test — 57 indicators
- "Respiratory System Health" Test — 22 indicators
- "Mental Health and Personality" Test — 39 indicators
- "Sleep and Circadian Rhythms" Test — 26 indicators
- "Addictions and Behavior" Test — 33 indicators
- "Eye and Ear Health" Test — 42 indicators
- "Dental and Oral Health" Test — 35 indicators
- "Skin, Hair and Appearance" Test — 51 indicators
- "Musculoskeletal System, Injury and Recovery" Test — 37 indicators
- "Athletic Potential and Physical Performance" Test — 25 indicators
- "Longevity and Biological Aging" Test — 53 indicators
- Special sections of the Report (included automatically in the Ultima Panel)
- Genetic report in PDF format
- Raw genetic data file
- One online consultation with a geneticist regarding the results of the Report
6. WARNINGS
6.1. The results of all Services are for informational purposes only and reflect genetic predispositions, not the presence of a disease. They are not a medical diagnosis, do not replace a doctor's consultation, and cannot be a basis for self-medication.
6.2. The Contractor does not guarantee the detection of all possible genetic variants — the scope of the analysis is limited by the current state of science, the genotyping technology applied and the capabilities of wellness interpretation.
6.3. Complex indicators describe a relative shift in predisposition compared with a reference population and are not a measurement of the indicator.
6.4. Individual genetic variants, including variants of genes associated with hereditary cancer syndromes, are determined by genotyping at predefined positions and are of a screening nature. Such a result is not a diagnosis and cannot be a basis for medical decisions: for clinical use it requires independent confirmation by a validated diagnostic method in an accredited clinical laboratory and a consultation with a medical geneticist. The absence of a detected variant does not exclude the presence of other variants in the same gene, since the analysis covers only selected positions and not the full sequence of the gene.